Key result
Severe pediatric obesity linked to ~49% higher prediabetes odds in boys vs class 1.
Why the study?
Does higher %BMI increase the likelihood of cardiometabolic risk factors in children and adolescents with obesity?
Cross-Sectional (n=1,761)
Does higher %BMI increase the likelihood of cardiometabolic risk factors in children and adolescents with obesity?
Higher %BMI in obese children and adolescents is linearly associated with a greater likelihood of prediabetes, insulin resistance, and elevated liver enzymes.
The prevalence of pediatric obesity, particularly severe obesity, is rising rapidly in China. Few studies have examined the relationship between body mass index (BMI) expressed as percentages of obesity thresholds (%BMI) and cardiometabolic risks in Chinese pediatric population. This study aims to evaluate the dose-response relationship between %BMI and cardiometabolic risk factors among children and adolescents in Beijing. This retrospective cross-sectional study utilized electronic health records (EHRs) of children and adolescents aged 7–18 years with obesity attending a specialized clinic. Anthropometric and laboratory data were extracted and validated. Individuals were categorized into class 1 obesity (BMI 100–120% of the obesity thresholds), class 2 (120–140%), and class 3 (≥ 140%). Logistic regression assessed the associations between obesity subcategories and four cardiometabolic risk factors, including prediabetes, dyslipidemia, insulin resistance (IR), and elevated liver enzymes. Restricted cubic spline (RCS) models were used to investigate the dose-response relationship between %BMI and cardiometabolic risk factors. Among 1,761 included individuals, class 3 obesity was associated with significantly higher odds of prediabetes (OR = 1.49 [95% CI: 1.01–2.19] for boys; OR = 2.91 [95% CI: 1.57–5.41] for girls), IR (OR = 4.40 [95% CI: 2.66–7.51] for boys; OR = 3.52 [95% CI: 1.63–8.35] for girls), and elevated liver enzymes (OR = 2.65 [95% CI: 1.81–3.93] for boys; OR = 2.97 [95% CI: 1.65–5.47] for girls) compared to class 1. Linear dose-response relationships were observed between %BMI and these factors. Dyslipidemia and its components (e.g., low high-density lipoprotein cholesterol and high triglyceride) exhibited complex dose-response relationships that varied by sex and Tanner Stage. Among obese children and adolescents in Beijing, higher %BMI might be linearly associated with greater likelihood of prediabetes, IR, and elevated liver enzymes, while dyslipidemia exhibits sex- and puberty-specific patterns. Further researches are required to characterize cardiometabolic risks across the obesity spectrum in Chinese pediatric population to inform targeted interventions.
No takes yet. Share an insight, caveat, or question.
Xiao et al. (2026) conducted a cross-sectional in Obesity (n=1,761). Class 3 obesity (BMI ≥ 140% of obesity threshold) vs. Class 1 obesity (BMI 100-120% of obesity threshold) was evaluated on Prediabetes (boys) (OR 1.49, 95% CI 1.01-2.19). Class 3 obesity (vs class 1) in children and adolescents was associated with higher odds of prediabetes (OR 1.49 in boys, 2.91 in girls), insulin resistance, and elevated liver enzymes.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: